Taro Pharma (TARO) Misses Q2 EPS by 36c, Approves Special Dividend

Go back to Taro Pharma (TARO) Misses Q2 EPS by 36c, Approves Special Dividend

Taro Pharma (TARO) Halted, News Pending

November 5, 2018 2:19 PM EST

Taro Pharma (NYSE: TARO) Halted, News Pending

... More